Recently we published our concerns regarding the published 2023 ACR/EULAR antiphospholipid syndrome (APS) classification criteria (1). Based on our publication dr. Tripodi wrote a reply (2). This has stimulated us to write a short reply to Tripodi’s publication.
For the details of pour reply, please read the complete publication: Antiphospholipid antibody solid phase-based assays: problems and proposed solutions for the 2023 ACR/EULAR classification criteria for antiphospholipid syndrome”: reply.” J Thromb Haemost, 2024; 22: 2373-2374.
This is publication can be approached via the following link: https://www-sciencedirect-com.eur.idm.oclc.org/science/article/pii/S1538783624002800
- Barbhaiya, M., S. Zuily, R. Naden, A. Hendry, F. Manneville, M.C. Amigo, et al., 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Ann Rheum Dis, 2023; 82: 1258-1270.
- Tripodi A. “Antiphospholipid antibody solid phase-based assays: problems and proposed solutions for the 2023 ACR/EULAR classification criteria for antiphospholipid syndrome”: comment. J Thromb 2024;22:2371–2.